albumin chromated cr-51 serum
Drug data last refreshed 5d ago · AI intelligence enriched 2w ago
CHROMALBIN is a radiopharmaceutical diagnostic agent consisting of human serum albumin labeled with chromium-51, administered by injection for diagnostic imaging purposes. It is used to visualize and assess blood pool distribution, cardiac function, and vascular integrity in nuclear medicine procedures. The product functions as a tracer agent, allowing clinicians to non-invasively monitor circulatory and organ-specific blood flow patterns.
This legacy diagnostic radiopharmaceutical faces declining clinical adoption as newer imaging modalities replace traditional nuclear medicine; team size and investment are likely minimal.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on CHROMALBIN offers minimal career growth or visibility; roles are primarily operational or compliance-focused rather than strategic or innovation-driven. Career advancement typically requires transition to growth-stage products or divisions.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.